Ranitidine and cimetidine differ in their in vitro and in vivo effects on human colonic cancer growth
1996

Effects of Ranitidine and Cimetidine on Colon Cancer Growth

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): JA Lawson, WJ Adams, DL Morris

Primary Institution: UNSW Department of Surgery, The St. George Hospital

Hypothesis

The study aims to examine the effect of ranitidine on the growth of colon cancer and its effect on histamine-sensitive colorectal cancer cell lines.

Conclusion

Ranitidine did not inhibit the growth of colon cancer cells, unlike cimetidine, which significantly reduced tumor growth.

Supporting Evidence

  • Ranitidine did not inhibit in vitro proliferation of C170 cells.
  • Cimetidine produced a 39.3% inhibition of tumor volume after treatment.
  • Ranitidine significantly stimulated tumor growth in LIM2412 cells.

Takeaway

Ranitidine, a medicine for stomach issues, doesn't help fight colon cancer like cimetidine does.

Methodology

The study involved in vitro assays on cancer cell lines and in vivo experiments using nude mice to assess tumor growth.

Potential Biases

Potential bias due to the limited scope of cell lines and the specific conditions under which the experiments were conducted.

Limitations

The study did not explore the effects of ranitidine on all possible cancer cell lines or in different conditions.

Participant Demographics

The study used human colorectal cancer cell lines derived from patients.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication